Back
Chugai Pharmaceutical Vs. Nxera Pharma Industry Stock Comparison
Buy
60
CHGCY
Chugai Pharmaceutical
Last Price:
23.95
Seasonality Move:
2%
Sell
50
SOLTF
Nxera Pharma
Last Price:
9.15
Seasonality Move:
13.13%
Buy
60
Chugai Pharmaceutical (CHGCY)
is a Buy
Is Chugai Pharmaceutical a Buy, Sell or Hold?
- The current Chugai Pharmaceutical [CHGCY] share price is $23.95. The Score for CHGCY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- CHGCY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Nxera Pharma (SOLTF)
is a Sell
Is Nxera Pharma a Buy, Sell or Hold?
- The current Nxera Pharma [SOLTF] share price is $9.15. The Score for SOLTF is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- SOLTF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CHGCY Stock Price Chart
What is Chugai Pharmaceutical's stock price today?
-
The Chugai Pharmaceutical share price today is $23.95
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CHGCY is experiencing buying pressure, which is a positive indicator for future bullish movement.
SOLTF Stock Price Chart
What is Nxera Pharma's stock price today?
-
The Nxera Pharma share price today is $9.15
The current trend is relatively stagnant and SOLTF is experiencing slight buying pressure.
CHGCY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.44 | Buy |
| Relative Strength Index (14 RSI): | 56.21 | Buy |
| Chaikin Money Flow: | 20223 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.16 - 24.7) | Buy |
| Bollinger Bands (100): | (15.92 - 22.64) | Buy |
SOLTF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.26 | Sell |
| Relative Strength Index (14 RSI): | 51.38 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.44 - 9.72) | Buy |
| Bollinger Bands (100): | (8.97 - 10.21) | Sell |
CHGCY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.84 | Buy |
| 20-day SMA: | 24.04 | Sell |
| 50-day SMA: | 22.18 | Buy |
| 200-day SMA: | 19 | Buy |
| 8-day EMA: | 23.85 | Buy |
| 20-day EMA: | 23.6 | Buy |
| 50-day EMA: | 22.23 | Buy |
| 200-day EMA: | 19.07 | Buy |
SOLTF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.57 | Buy |
| 20-day SMA: | 8.99 | Buy |
| 50-day SMA: | 9.69 | Sell |
| 200-day SMA: | 9.81 | Sell |
| 8-day EMA: | 8.8 | Buy |
| 20-day EMA: | 8.96 | Buy |
| 50-day EMA: | 9.36 | Sell |
| 200-day EMA: | 10.06 | Sell |
Chugai Pharmaceutical Earnings Growth & CHGCY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nxera Pharma Earnings Growth & SOLTF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Chugai Pharmaceutical Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nxera Pharma Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||